<DOC>
	<DOCNO>NCT01785004</DOCNO>
	<brief_summary>The VITamin D OmegA-3 TriaL ( VITAL ; NCT 01169259 ) randomize clinical trial 20,000 U.S. men woman investigate whether take daily dietary supplement vitamin D3 ( 2000 IU ) omega-3 fatty acid ( 1 gram omega-3 fatty acid ) reduces risk develop cancer , heart disease , stroke people prior history illness . This ancillary study ( VITAL Adiposity ) conduct among participant VITAL examine effect vitamin D fish oil change body composition adiposity ( baseline compare 2 year , measure anthropometric index , total regional body fat adipokines ) assess whether change cardiovascular risk factor ( lipid , glucose tolerance , blood pressure ) mediate parameter . How achieved 25 ( OH ) D level affect body composition body mass also assess .</brief_summary>
	<brief_title>Vitamin D Omega-3 Adiposity Trial ( VITAL Adiposity )</brief_title>
	<detailed_description>Observational study suggest low 25-hydroxyvitamin D ( 25 ( OH ) D ) level associate high BMI fat mass ( FM ) , unknown whether vitamin D supplementation alter body composition adiposity . Despite enthusiasm use vitamin D supplement reduce FM , hypothesis vitamin D modify adiposity remain unproven . Finding strategy prevent obesity critical public health importance due high prevalence overweight/obesity role cause diabetes , hypertension , dyslipidemia , cardiovascular disease ( CVD ) , among others . Observational study also link low 25 ( OH ) D level CVD risk factor related obesity , sequestration vitamin D fat tissue may confound factor . The effect vitamin D supplementation body composition , adiposity CVD risk factor best test randomized clinical trial ( RCT ) , accord Institute Medicine ( IOM ) 2011 report , data randomize clinical trial outcomes need . Previous trial vitamin D limit inability separate effect supplemental calcium vitamin D , small sample size , insufficient vitamin D dose , failure monitor 25 ( OH ) D level inadequate ascertainment body composition . The NIH-funded VITamin D OmegA-3 TriaL ( VITAL ) ( 1 U01 CA138962 ) affords unique cost-effective opportunity investigate effect vitamin D change body composition ass whether change CVD risk factor mediate , least part , parameter . VITAL large-scale , randomize , primary prevention trial test 2000 IU/d vitamin D3 ( cholecalciferol ) 1 g/day omega-3 fatty acid ( 840 mg EPA+DHA 1.3:1 ratio ) 2x2 factorial design among 20,000 men woman ( ≥50 ≥55 year , respectively ) , mean participant follow-up 5 year CVD cancer . This ancillary study address understudied area two overarch hypothesis vitamin D supplementation ( 1 ) lower total regional ( trunkal abdominal/androidal ) body fat measure dual x-ray absorptiometry ( DXA ) scan , improve biomarkers adiposity ( leptin , adiponectin ) ( 2 ) impact CVD risk factor , least part adiposity . The investigator also seek define circulating achieve 25 ( OH ) D level , due supplementation , may affect body composition BMI , thus elucidate adiposity , BMI , body composition ( total regional ) may influence vitamin D intake need population . To critically evaluate hypothesis , investigator examine representative , randomize subcohort 1000 racially diverse VITAL participant ( 25 % African American ) two year .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Inclusion criterion : Participants VITAL ( NCT 01169259 ) willing participate ancillary study undergo DXA evaluation ( baseline 2 year ) Exclusion criterion : Inability travel Clinical Translational Science Center Boston imaging , anthropometric measurement , blood work perform .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Adiposity</keyword>
	<keyword>Body composition</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Adipokines</keyword>
	<keyword>Omega-3 fatty acid</keyword>
</DOC>